IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 10 holdings | $670.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Springworks Therapeutics IncCOM85205L107$280.3K7,281,30741.8%
Constellation Pharmaceuticals Inc.(CNST)COM210373106$133.0K2,823,52919.8%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$89.9K4,080,23713.4%
Dynavax Technologies Corp.(DVAX)COM268158201$48.3K8,452,2357.2%
Replimune Group Inc(REPL)COM76029N106$40.7K2,838,9686.1%
Savara Inc(SVRA)COM805111101$23.0K5,128,5933.4%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$17.6K1,648,4852.6%
Solid Biosciences IncCOM83422E105$17.2K3,871,1642.6%
Marinus Pharmaceuticals IncCOM56854Q101$12.8K5,942,7351.9%
Aptinyx IncCOM03836N103$7.6K2,225,0921.1%